Correction of Stock Option Grant Due to 5:1 Reverse Split (400,000 shares, exercise price 3,445 KRW)
Due to 5:1 reverse stock split, the exercise price of previously granted stock options adjusted from 689 KRW to 3,445 KRW, and the number of shares from 2,000,000 to 400,000
The granted shares represent 5.35% of total outstanding shares (7,469,660 shares)
Exercise price of 3,445 KRW is significantly above current price of 391 KRW, making exercise unlikely
Grant beneficiaries: registered director LIN JINSHENG (200,000 shares), affiliates JIN MEIHUA (100,000) and LIU FENFANG (60,000), auditor LIN XIAO (40,000)
Exercise period: from October 28, 2027 to October 27, 2035 (8 years), settlement by new share issuance
KOSDAQ Filing Information
Filing: [Correction of Description] Report on Grant of Stock Options
Company: CXI Healthcare Technology Group (900120)
Submission: CXI Healthcare Technology Group Limited